Search - tctmd.com

Displaying 641 - 660 of 4684

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1495: Metal-Free CHIP PCI for Ostial LCX CTO in AMI-CS: Simple Solution for Complex Problem

Presenter: Stalin Justin

October 27, 2024

Presentation TCT 2024

TCT 1536: Drug-Coated Balloons: A Novel Option for Cardiac Allograft Vasculopathy

Presenter: Clara Fernandez Cordon

October 27, 2024

Presentation TCT 2024

TCT 539: Pre-procedural Planning for Left Atrial Appendage Occlusion by a Novel CT Scan Software

Presenter: Ngai-Yin Chan

October 27, 2024

Presentation TCT 2024

Is There Still Room to Improve the Coronary Tools?

Presenter: Elliot Smith

October 27, 2024

Presentation TCT 2024

TCT 1216: Novel Approach to a CTO

Presenter: Gavin Manmathan

October 27, 2024

Presentation TCT 2024

TCT 1408: Pentafurcation of LAD Treated With Drug Eluting Baloom

Presenter: Mahpaekar Mashhadi

October 27, 2024

Presentation TCT 2024

TCT 1251: Adapting the Culotte: From Bench Testing to Complete Longitudinal Analysis of the First-in-Human Culotte Technique With Double Bioadaptors

Presenter: Chin Wai Lai

October 27, 2024

Presentation TCT 2024

TCT 1124: PCI to Total ISR of Cx Ostium After TAP for Distal LM Disease

Presenter: Mohammad Shafiq

October 27, 2024

Presentation TCT 2024

TCT 1463: Improvement in Coronary Microcirculatory Function With A-FLUX Next-Generation Coronary Sinus Reducer

Presenter: Manel Sabate

October 27, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Daily News

Defying Earlier GLP-1 Data, Study in Teens Sees Possible Mental Health Gains

L.A. McKeown

October 22, 2024

News Conference News EACTS 2024

AI-Based CT Can Accurately Screen Patients for TMVR

Yael L. Maxwell

October 15, 2024

News Daily News

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Michael O'Riordan

October 14, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Conference News HFSA 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Michael O'Riordan

October 03, 2024

News Conference News HFSA 2024

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

Todd Neale

October 01, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Medicaid Coverage Improves CV Risk in Some, Post Hoc Analysis Shows

Todd Neale

September 25, 2024

News Daily News

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Yael L. Maxwell

September 23, 2024

Advertisement

TCT 1495: Metal-Free CHIP PCI for Ostial LCX CTO in AMI-CS: Simple Solution for Complex Problem

TCT 1536: Drug-Coated Balloons: A Novel Option for Cardiac Allograft Vasculopathy

TCT 539: Pre-procedural Planning for Left Atrial Appendage Occlusion by a Novel CT Scan Software

Is There Still Room to Improve the Coronary Tools?

TCT 1216: Novel Approach to a CTO

TCT 1408: Pentafurcation of LAD Treated With Drug Eluting Baloom

TCT 1251: Adapting the Culotte: From Bench Testing to Complete Longitudinal Analysis of the First-in-Human Culotte Technique With Double Bioadaptors

TCT 1124: PCI to Total ISR of Cx Ostium After TAP for Distal LM Disease

TCT 1463: Improvement in Coronary Microcirculatory Function With A-FLUX Next-Generation Coronary Sinus Reducer

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

Defying Earlier GLP-1 Data, Study in Teens Sees Possible Mental Health Gains

AI-Based CT Can Accurately Screen Patients for TMVR

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Will Semaglutide Change Cardiac Surgery? It Already Has

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Medicaid Coverage Improves CV Risk in Some, Post Hoc Analysis Shows

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content